The 'Cancer Moonshot,' One Year After Takeoff

at 10:00 AM
Save ArticleSave Article

Failed to save article

Please try again

This article is more than 6 years old.
Youssef Cohen gets checked by a nurse before underdoing cancer treatment on March 16, 2016 in New York City. Cohen, 68, has an incurable cancer called mesothelioma and is advocating for the right to choose how and when he will die, proposed in New York State's End of Life Options Act. (Photo: John Moore/Getty Images)

This year, more than 1.6 million cases of cancer will be diagnosed in the United States. More than 600,000 Americans are expected to die of the disease. That's the backdrop with which the White House launched the National Cancer Moonshot Initiative last year. Its goal is to achieve a decade's worth of progress in the battle against cancer in only five years. Led by Vice President Joe Biden who visited San Francisco earlier this week to discuss the ambitious project, Moonshot calls on doctors, nurses, researchers and patients to identify what is really needed to gain ground on the big C. This hour, we'll find out where the Moonshot stands one year in and discuss its future under a Trump administration.

Resources Recommended by Our Guests:


Matthew Ong, reporter, The Cancer Letter

Deborah Mayer, professor, school of nursing and director of cancer survivorship, UNC Lineberger Comprehensive Cancer Center at UNC-Chapel Hill; member, Blue Ribbon Panel for Vice President Biden’s Cancer Moonshot

Jan Liphardt, associate professor of bioengineering, Stanford University; co-founder,

Alan Ashworth, president, UCSF Helen Diller Family Comprehensive Cancer Center; senior vice president for Cancer Services, UCSF Health Professor of Medicine